Evidence map›Paper›PMID 28977971›Full record

ArticleOncotarget2017

Meta-analysis of SIRT1 expression as a prognostic marker for overall survival in gastrointestinal cancer.

Shuangjie Wu, Jinghui Jiang, Jun Liu, Xinhai Wang, Yu Gan, Yifan Tang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Cerebrovascular disease is associated with the risk of mortality in coronavirus disease 2019.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Pooled it
  2. Pooled it
  3. Exploring the Role ofJournal of clinical medicine · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.Recent advances in inflammation & allergy drug discovery · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. SIRT1 in Secretory Organ Cancer.Frontiers in endocrinology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Shuangjie WuDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Jinghui JiangState Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
Jun LiuDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Xinhai WangDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Yu GanState Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200032, China.
Yifan TangDepartment of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Huashan Hospital · CNFudan University · CNRenji Hospital · CNShanghai Cancer Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sirtuin 1 (SIRT1), a well-characterized NAD

Indexed as

gastrointestinal cancermeta-analysisoverall survivalprognosisSIRT1

Identifiers

PMID28977971
PMCPMC5617531
OpenAlexW2744008920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.